[1]
C. Xu, Y. Xiao, Y. Wu, A. Bakker, and Y. Liu, “Impaired Osteoclastogenesis in Medication-Related Osteonecrosis and Potential Clinical Management with BMP-2”, RMD, vol. 1, no. 1, p. 5, Dec. 2024. doi: 10.53941/rmd.2024.100005.